J&J expands Phase 2a COVID-19 vaccine trial to include adolescents
The vaccine candidate will initially be tested in a small number of adolescents aged 16-17 years
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.